STOCKHOLM, Oct 10 (Reuters) - Meda Ab :
* Complete terms and conditions of the rights issue, including subscription price, are expected to be announced no later than 6 November 2014. Subject to the approval of the rights issue by the Extraordinary General Meeting, the subscription period will run from 19 November up to and including 4 December 2014.
* The purpose of the rights issue is to finance part of the acquisition of Rottapharm. Further company coverage: (Reporting by Stockholm newsroom)